Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2026-05-13 @ 7:37 AM
Study NCT ID:
NCT02328261
Status:
UNKNOWN
Last Update Posted:
2014-12-31
First Post:
2014-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Nasopharyngeal Carcinoma | View |
Keywords: